Cambridge Advisors Inc. Baxter International Inc Transaction History

Cambridge Advisors Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$63.83 - $80.0 $177,255 - $222,160	-2,777 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$76.85 - $89.45 $614 - $715	8 Added 0.29%	2,777 $215,000
Q4 2021 Jan 14, 2022	BUY	$74.57 - $87.19 $596 - $697	8 Added 0.29%	2,769 $238,000
Q3 2021 Oct 19, 2021	SELL	$73.77 - $83.61 $3,393 - $3,846	-46 Reduced 1.64%	2,761 $222,000
Q2 2021 Jul 21, 2021	BUY	$80.5 - $88.01 $25,277 - $27,635	314 Added 12.6%	2,807 $226,000
Q1 2021 Apr 22, 2021	BUY	$76.38 - $86.03 $190,415 - $214,472	2,493 New	2,493 $210,000
Q3 2020 Oct 15, 2020	SELL	$78.33 - $90.73 $190,576 - $220,746	-2,433 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$78.66 - $94.14 $191,379 - $229,042	2,433 New	2,433 $209,000
Q1 2020 Apr 21, 2020	SELL	$71.57 - $93.3 $173,199 - $225,786	-2,420 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$76.7 - $88.45 $185,614 - $214,049	2,420 New	2,420 $202,000
Q3 2018 Oct 24, 2018	SELL	$70.71 - $77.75 $210,715 - $231,695	-2,980 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$63.43 - $75.41 $189,021 - $224,721	2,980 New	2,980 $220,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Cambridge Advisors Inc. with notifications on news.